University College London Hospitals NHS Foundation Trust

Specialist MDT: University College London Hospitals NHS Foundation Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services (updated 2019):

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy
    • Intensity-modulated radiotherapy
    • High-dose rate brachytherapy
    • Stereotactic body radiation therapy (SBRT)
    • HIFU
    • Cryotherapy
    • Chemotherapy
    • Joint specialist MDT clinic
  • Support Service Facilities:
    • Prostate cancer clinical nurse specialist (PCa CNS)
    • Advanced PCa CNS
    • Urology CNS
    • Oncology CNS
    • Sexual function services
    • Specialist continence services

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 372 1028
Performance Status recorded 14% 25%
PSA completed 21% 59%
Gleason Score completed 95% 86%
TNM completed 89% 89%
Risk group assigned 96% 92%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 983 49027
Percentage of men diagnosed with metastatic disease 7% 13%

Management

Specialist MDT National
No. of men diagnosed with low-risk localised disease 22 3055
Percentage of men with low-risk localised disease receiving radical treatment 0% 5%
No. of men diagnosed with locally advanced disease 371 19663
Percentage of men diagnosed with locally advanced disease receiving radical treatment 64% 71%
No. of men diagnosed with M1 (metastases) 72 6136
Percentage of men diagnosed with M1 (metastases) receiving docetaxel 29% 36%

Patient experience of care

Specialist MDT National
No. of men diagnosed 1st April 18 - 30th Sept 18 who had radical treatment (surgery or radiotherapy) and were sent a questionnaire 203 10750
Percentage of men who responded 71% 78%
No. of men who completed CNS question 141 8137
Percentage of men who were ‘given the name of a CNS’ 87% 87%
No. of men who rated their overall care on a scale of 1-10 132 7878
Percentage of men who rated their overall care as 8 or above 92% 91%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2018-2019) 691
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 7%
No. of men who received radical prostatectomy (2017) 404
Adjusted percentage of men experiencing at least one GU complication requiring a procedural/surgical intervention (%) 5%
No. of men who received radical radiotherapy (2017) 49
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%) 26%

Patient-reported outcomes

Treatment Centre
No. of men diagnosed 1st April 18 - 30th Sept 18 who received radical prostatectomy and were sent a questionnaire 246
Percentage of men who responded 67%
No. of men who completed sufficient information for a validated EPIC-26 urinary incontinence score to be determined 154
Adjusted EPIC-26 urinary incontinence score (0=worst to 100=best) 77
No. of men who completed sufficient information for a validated EPIC-26 sexual function score to be determined 159
Adjusted EPIC-26 sexual function score (0=worst to 100=best) 28
No. of men diagnosed 1st April 18 - 30th Sept 18 who received external beam radiotherapy and were sent a questionnaire 17
Percentage of men who responded 71%
No. of men who completed sufficient information for a validated EPIC-26 bowel function score to be determined 12
Adjusted EPIC-26 bowel function score (0=worst to 100=best) 87
No. of men who completed sufficient information for a validated EPIC-26 sexual function score to be determined 12
Adjusted EPIC-26 sexual function score (0=worst to 100=best) 14

Compare provider outcomes